Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 20, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012975.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
piezo-type mechanosensitive ion channel component 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
zinc finger E-box-binding homeobox 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
VAMP (vesicle-associated membrane protein)-associated protein B and C
vesicle-associated membrane protein-associated protein B/C
RAB22A, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
RAB22A, member RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein phosphatase 4, regulatory subunit 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein phosphatase 4, regulatory subunit 1-like, transcript variant X1
serine/threonine-protein phosphatase 4 regulatory subunit 1
ankyrin repeat domain-containing protein 60-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
androgen-induced gene 1 protein-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
androgen-induced gene 1 protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
androgen-induced gene 1 protein-like isoform X3
androgen-induced gene 1 protein-like, transcript variant X2
androgen-induced gene 1 protein-like, transcript variant X1
androgen-induced gene 1 protein-like isoform X2
uncharacterized protein LOC122559975 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CD83 antigen-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CD83 antigen-like, transcript variant X2
CD83 antigen-like, transcript variant X3
uncharacterized protein LOC122559896 isoform X3
WAP four-disulfide core domain protein 3
deoxynucleotidyltransferase terminal-interacting protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
phosphorylated CTD interacting factor 1, transcript variant X1
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase isoform X1
phosphorylated CTD interacting factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
phosphorylated CTD interacting factor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phosphorylated CTD interacting factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase isoform X2
phospholipid transfer protein, transcript variant X2
phospholipid transfer protein, transcript variant X4
phospholipid transfer protein, transcript variant X1
phospholipid transfer protein, transcript variant X3
cytochrome c oxidase subunit 4 isoform 1, mitochondrial-like, transcript variant X2
cytochrome c oxidase subunit 4 isoform 1, mitochondrial-like, transcript variant X1
cytochrome c oxidase subunit 4 isoform 1, mitochondrial-like
apoptosis regulator R11-like, transcript variant X1
apoptosis regulator R11-like, transcript variant X2
apoptosis regulator R11-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
TPX2 microtubule nucleation factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
TPX2 microtubule nucleation factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
protein TMEPAI-like, transcript variant X1
protein TMEPAI-like, transcript variant X2
myosin light chain kinase 2, skeletal/cardiac muscle-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
family with sequence similarity 217 member Ba, transcript variant X2
family with sequence similarity 217 member Ba, transcript variant X1
uncharacterized protein fam217ba isoform X1
uncharacterized protein fam217ba isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
tubulin tyrosine ligase-like family, member 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
protein SYS1 homolog, transcript variant X4
protein SYS1 homolog, transcript variant X3
protein SYS1 homolog, transcript variant X1
protein SYS1 homolog, transcript variant X2
negative elongation factor complex member C/D, transcript variant X2
negative elongation factor complex member C/D, transcript variant X1
negative elongation factor C/D isoform X2
negative elongation factor C/D isoform X1
GNAS complex locus, transcript variant X1
guanine nucleotide-binding protein G(s) subunit alpha isoform X1
GNAS complex locus, transcript variant X2
guanine nucleotide-binding protein G(s) subunit alpha isoform X2
GNAS complex locus, transcript variant X3
guanine nucleotide-binding protein G(s) subunit alpha isoform X3
bactericidal permeability-increasing protein-like, transcript variant X1
bactericidal permeability-increasing protein-like, transcript variant X2
bactericidal permeability-increasing protein-like
solute carrier family 35 member C2, transcript variant X1
solute carrier family 35 member C2, transcript variant X2
solute carrier family 35 member C2 isoform X1
solute carrier family 35 member C2 isoform X2
engulfment and cell motility protein 2-like
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
small nuclear ribonucleoprotein polypeptides B and B1
small nuclear ribonucleoprotein-associated proteins B and B'
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27
probable ATP-dependent RNA helicase DDX27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 273 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
nucleoside diphosphate-linked moiety X motif 19-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nucleoside diphosphate-linked moiety X motif 19-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
cleavage stimulation factor, 3' pre-RNA, subunit 1, transcript variant X2
cleavage stimulation factor, 3' pre-RNA, subunit 1, transcript variant X3
nucleoside diphosphate-linked moiety X motif 19-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
cleavage stimulation factor, 3' pre-RNA, subunit 1, transcript variant X5
cleavage stimulation factor, 3' pre-RNA, subunit 1, transcript variant X1
cleavage stimulation factor, 3' pre-RNA, subunit 1, transcript variant X4
enhancer of filamentation 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
enhancer of filamentation 1-like isoform X2
enhancer of filamentation 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
enhancer of filamentation 1-like isoform X1
AP-1 complex subunit gamma-1-like, transcript variant X3
AP-1 complex subunit gamma-1-like, transcript variant X2
AP-1 complex subunit gamma-1-like, transcript variant X1
AP-1 complex subunit gamma-1-like, transcript variant X4
AP-1 complex subunit gamma-1-like isoform X2
AP-1 complex subunit gamma-1-like isoform X1
AP-1 complex subunit gamma-1-like isoform X3
tumor necrosis factor receptor superfamily member 5-like
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122560008, transcript variant X1
uncharacterized LOC122560008, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
troponin C, skeletal muscle-like, transcript variant X1
troponin C, skeletal muscle-like, transcript variant X2
troponin C, skeletal muscle-like isoform X1
troponin C, skeletal muscle-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
neuralized E3 ubiquitin protein ligase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 335, transcript variant X1
zinc finger protein 335, transcript variant X2
zinc finger protein 335, transcript variant X3
zinc finger protein 335, transcript variant X4
ankyrin repeat domain-containing protein SOWAHA-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ankyrin repeat domain-containing protein SOWAHC-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC122560018, transcript variant X1
uncharacterized LOC122560018, transcript variant X2
uncharacterized LOC122560018, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
bactericidal permeability-increasing protein-like, transcript variant X4
bactericidal permeability-increasing protein-like, transcript variant X6
bactericidal permeability-increasing protein-like, transcript variant X3
bactericidal permeability-increasing protein-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
bactericidal permeability-increasing protein-like isoform X2
bactericidal permeability-increasing protein-like isoform X1
bactericidal permeability-increasing protein-like isoform X3
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
bactericidal permeability-increasing protein-like, transcript variant X8
bactericidal permeability-increasing protein-like isoform X4
bactericidal permeability-increasing protein-like, transcript variant X5
CDK5 regulatory subunit associated protein 1
CDK5 regulatory subunit-associated protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
pleckstrin homology domain-containing family G member 4B-like, transcript variant X1
pleckstrin homology domain-containing family G member 4B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pleckstrin homology domain-containing family G member 4B-like, transcript variant X3
pleckstrin homology domain-containing family G member 4B-like isoform X1
pleckstrin homology domain-containing family G member 4B-like isoform X2
pleckstrin homology domain-containing family G member 4B-like, transcript variant X4
pleckstrin homology domain-containing family G member 4B-like isoform X3
protein-glutamine gamma-glutamyltransferase 2-like, transcript variant X2
protein-glutamine gamma-glutamyltransferase 2-like, transcript variant X1
protein-glutamine gamma-glutamyltransferase 2-like isoform X1
protein-glutamine gamma-glutamyltransferase 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
V-set and transmembrane domain-containing protein 2-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X2
regulation of nuclear pre-mRNA domain containing 1B, transcript variant X1
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X1
regulation of nuclear pre-mRNA domain-containing protein 1B isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
protein-glutamine gamma-glutamyltransferase 2-like, transcript variant X3
protein-glutamine gamma-glutamyltransferase 2-like, transcript variant X4
protein-glutamine gamma-glutamyltransferase 2-like, transcript variant X5
protein-glutamine gamma-glutamyltransferase 2-like isoform X3
protein-glutamine gamma-glutamyltransferase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zinc finger, NFX1-type containing 1, transcript variant X2
zinc finger, NFX1-type containing 1, transcript variant X3
zinc finger, NFX1-type containing 1, transcript variant X1
zinc finger, NFX1-type containing 1, transcript variant X5
zinc finger, NFX1-type containing 1, transcript variant X4
NFX1-type zinc finger-containing protein 1 isoform X2
NFX1-type zinc finger-containing protein 1 isoform X1
NFX1-type zinc finger-containing protein 1 isoform X3
aurora kinase C-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
aurora kinase C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
family with sequence similarity 210 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 106 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122560035, transcript variant X2
uncharacterized LOC122560035, transcript variant X3
uncharacterized LOC122560035, transcript variant X1
uncharacterized protein LOC122560035 isoform X1
uncharacterized protein LOC122560035 isoform X2
uncharacterized protein LOC122560035 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC122559902, transcript variant X1
uncharacterized LOC122559902, transcript variant X2
docking protein 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
docking protein 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
docking protein 5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
prefoldin subunit 4, transcript variant X1
prefoldin subunit 4, transcript variant X3
prefoldin subunit 4, transcript variant X2
teashirt homolog 2, transcript variant X1
teashirt homolog 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
teashirt homolog 2, transcript variant X4
teashirt homolog 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
teashirt homolog 2, transcript variant X5
zinc finger protein 217, transcript variant X4
zinc finger protein 217, transcript variant X2
zinc finger protein 217, transcript variant X8
zinc finger protein 217, transcript variant X9
zinc finger protein 217, transcript variant X1
zinc finger protein 217, transcript variant X3
zinc finger protein 217, transcript variant X7
zinc finger protein 217, transcript variant X5
zinc finger protein 217, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
breast carcinoma-amplified sequence 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
breast carcinoma-amplified sequence 1-like, transcript variant X1
breast carcinoma-amplified sequence 1-like, transcript variant X3
breast carcinoma-amplified sequence 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
breast carcinoma-amplified sequence 1-like isoform X3
breast carcinoma-amplified sequence 1-like isoform X2
breast carcinoma-amplified sequence 1-like isoform X1
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial, transcript variant X2
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial, transcript variant X1
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform X1
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform X2
spalt-like transcription factor 4, transcript variant X1
spalt-like transcription factor 4, transcript variant X2
probable phospholipid-transporting ATPase IIA
nuclear factor of activated T cells 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nuclear factor of activated T cells 2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nuclear factor of activated T-cells, cytoplasmic 2 isoform X2
nuclear factor of activated T-cells, cytoplasmic 2 isoform X1
uncharacterized LOC122560058, transcript variant X2
uncharacterized LOC122560058, transcript variant X1
potassium voltage-gated channel, subfamily G, member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel, subfamily G, member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium voltage-gated channel, subfamily G, member 1, transcript variant X4
potassium voltage-gated channel, subfamily G, member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel, subfamily G, member 1, transcript variant X5
potassium voltage-gated channel subfamily G member 1
dolichyl-phosphate mannosyltransferase subunit 1, catalytic, transcript variant X1
dolichol-phosphate mannosyltransferase subunit 1 isoform X1
dolichyl-phosphate mannosyltransferase subunit 1, catalytic, transcript variant X2
dolichol-phosphate mannosyltransferase subunit 1 isoform X2
activity-dependent neuroprotector homeobox b
breast carcinoma-amplified sequence 4-like
partitioning defective 6 homolog beta-like
RIPOR family member 3, transcript variant X2
RIPOR family member 3, transcript variant X3
RIPOR family member 3, transcript variant X5
RIPOR family member 3, transcript variant X1
RIPOR family member 3, transcript variant X6
RIPOR family member 3, transcript variant X8
RIPOR family member 3, transcript variant X4
RIPOR family member 3, transcript variant X7
tyrosine-protein phosphatase non-receptor type 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC122559905, transcript variant X1
uncharacterized LOC122559905, transcript variant X2
ubiquitin-conjugating enzyme E2 variant 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF114-like, transcript variant X1
E3 ubiquitin-protein ligase RNF114-like, transcript variant X2
E3 ubiquitin-protein ligase RNF114-like, transcript variant X3
spermatogenesis associated 2, transcript variant X2
spermatogenesis associated 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 9 member 8, transcript variant X2
solute carrier family 9 member 8, transcript variant X1
beta-1,4-galactosyltransferase 5-like, transcript variant X3
beta-1,4-galactosyltransferase 5-like isoform X3
beta-1,4-galactosyltransferase 5-like, transcript variant X1
beta-1,4-galactosyltransferase 5-like, transcript variant X2
beta-1,4-galactosyltransferase 5-like isoform X1
beta-1,4-galactosyltransferase 5-like isoform X2
beta-1,4-galactosyltransferase 5-like, transcript variant X4
beta-1,4-galactosyltransferase 5-like isoform X4
cadherin-like protein 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cadherin-like protein 26, transcript variant X3
cadherin-like protein 26, transcript variant X2
cadherin-like protein 26, transcript variant X4
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
fibronectin type III domain-containing protein 11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
uncharacterized LOC122560078, transcript variant X2
uncharacterized LOC122560078, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ganglioside induced differentiation associated protein 1-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ganglioside-induced differentiation-associated protein 1-like 1
fat storage inducing transmembrane protein 2, transcript variant X1
fat storage inducing transmembrane protein 2, transcript variant X3
fat storage inducing transmembrane protein 2, transcript variant X2
acyl-coenzyme A diphosphatase FITM2 isoform X1
acyl-coenzyme A diphosphatase FITM2 isoform X2
fat storage inducing transmembrane protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
peptidase inhibitor 15-like, transcript variant X2
peptidase inhibitor 15-like, transcript variant X1
tocopherol (alpha) transfer protein-like, transcript variant X4
tocopherol (alpha) transfer protein-like, transcript variant X5
tocopherol (alpha) transfer protein-like, transcript variant X1
tocopherol (alpha) transfer protein-like, transcript variant X2
tocopherol (alpha) transfer protein-like, transcript variant X3
alpha-tocopherol transfer protein-like isoform X1
alpha-tocopherol transfer protein-like isoform X2
adenosine deaminase, transcript variant X3
adenosine deaminase, transcript variant X1
adenosine deaminase, transcript variant X4
adenosine deaminase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger, CCCH-type with G patch domain
zinc finger CCCH-type with G patch domain-containing protein
ADP-ribosylation factor related protein 1, transcript variant X1
ADP-ribosylation factor related protein 1, transcript variant X2
ADP-ribosylation factor-related protein 1 isoform X2
ADP-ribosylation factor-related protein 1 isoform X1
tumor necrosis factor receptor superfamily member 6B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
regulator of telomere elongation helicase 1, transcript variant X2
regulator of telomere elongation helicase 1, transcript variant X3
regulator of telomere elongation helicase 1, transcript variant X1
regulator of telomere elongation helicase 1, transcript variant X5
regulator of telomere elongation helicase 1, transcript variant X6
regulator of telomere elongation helicase 1 isoform X2
regulator of telomere elongation helicase 1 isoform X1
regulator of telomere elongation helicase 1 isoform X4
regulator of telomere elongation helicase 1 isoform X5
regulator of telomere elongation helicase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
regulator of telomere elongation helicase 1 isoform X3
glucocorticoid modulatory element binding protein 2, transcript variant X2
glucocorticoid modulatory element binding protein 2, transcript variant X1
glucocorticoid modulatory element-binding protein 2
thyrotropin-releasing hormone receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
thyrotropin-releasing hormone receptor-like, transcript variant X1
thyrotropin-releasing hormone receptor-like
uncharacterized LOC122560104, transcript variant X2
uncharacterized LOC122560104, transcript variant X1
protein FAM110B-like, transcript variant X5
protein FAM110B-like, transcript variant X2
protein FAM110B-like, transcript variant X1
protein FAM110B-like, transcript variant X3
protein FAM110B-like, transcript variant X4
protein FAM110B-like, transcript variant X6
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X3
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X2
sodium-dependent lysophosphatidylcholine symporter 1-like, transcript variant X1
sodium-dependent lysophosphatidylcholine symporter 1-like
extracellular sulfatase Sulf-2-like, transcript variant X4
extracellular sulfatase Sulf-2-like, transcript variant X6
extracellular sulfatase Sulf-2-like, transcript variant X1
extracellular sulfatase Sulf-2-like, transcript variant X5
extracellular sulfatase Sulf-2-like, transcript variant X3
extracellular sulfatase Sulf-2-like, transcript variant X7
extracellular sulfatase Sulf-2-like, transcript variant X8
extracellular sulfatase Sulf-2-like, transcript variant X9
extracellular sulfatase Sulf-2-like, transcript variant X2
extracellular sulfatase Sulf-2-like isoform X3
extracellular sulfatase Sulf-2-like isoform X2
extracellular sulfatase Sulf-2-like isoform X1
phosphatidylinositol-3,4, 5-trisphosphate-dependent Rac exchange factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122560112, transcript variant X2
uncharacterized LOC122560112, transcript variant X1
brefeldin A-inhibited guanine nucleotide-exchange protein 2-like
CSE1 chromosome segregation 1-like (yeast), transcript variant X1
CSE1 chromosome segregation 1-like (yeast), transcript variant X2
staufen double-stranded RNA binding protein 1, transcript variant X3
staufen double-stranded RNA binding protein 1, transcript variant X1
staufen double-stranded RNA binding protein 1, transcript variant X2
staufen double-stranded RNA binding protein 1, transcript variant X4
double-stranded RNA-binding protein Staufen homolog 1 isoform X1
double-stranded RNA-binding protein Staufen homolog 1 isoform X2
double-stranded RNA-binding protein Staufen homolog 1 isoform X4
double-stranded RNA-binding protein Staufen homolog 1 isoform X3
uncharacterized LOC122559910, transcript variant X2
uncharacterized LOC122559910, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00581
somatomedin-B and thrombospondin type-1 domain-containing protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
somatomedin-B and thrombospondin type-1 domain-containing protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
somatomedin-B and thrombospondin type-1 domain-containing protein isoform X1
somatomedin-B and thrombospondin type-1 domain-containing protein isoform X2
potassium voltage-gated channel, Shab-related subfamily, member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel, Shab-related subfamily, member 1, transcript variant X1
potassium voltage-gated channel, Shab-related subfamily, member 1, transcript variant X3
potassium voltage-gated channel subfamily B member 1
uncharacterized LOC122560119, transcript variant X1
uncharacterized LOC122560119, transcript variant X2
prostaglandin I2 (prostacyclin) synthase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
collagen alpha-1(XX) chain-like, transcript variant X3
collagen alpha-1(XX) chain-like, transcript variant X4
collagen alpha-1(XX) chain-like, transcript variant X5
collagen alpha-1(XX) chain-like, transcript variant X1
collagen alpha-1(XX) chain-like, transcript variant X2
collagen alpha-1(XX) chain-like isoform X2
collagen alpha-1(XX) chain-like isoform X3
collagen alpha-1(XX) chain-like isoform X1
DEP domain-containing mTOR-interacting protein-like, transcript variant X1
DEP domain-containing mTOR-interacting protein-like, transcript variant X5
DEP domain-containing mTOR-interacting protein-like, transcript variant X3
DEP domain-containing mTOR-interacting protein-like, transcript variant X6
DEP domain-containing mTOR-interacting protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
DEP domain-containing mTOR-interacting protein-like isoform X2
DEP domain-containing mTOR-interacting protein-like isoform X1
DEP domain-containing mTOR-interacting protein-like isoform X5
DEP domain-containing mTOR-interacting protein-like isoform X6
DEP domain-containing mTOR-interacting protein-like isoform X3
DEP domain-containing mTOR-interacting protein-like, transcript variant X7
DEP domain-containing mTOR-interacting protein-like isoform X7
DEP domain-containing mTOR-interacting protein-like, transcript variant X4
DEP domain-containing mTOR-interacting protein-like isoform X4
ADP-ribosylation factor GTPase activating protein 1, transcript variant X3
ADP-ribosylation factor GTPase activating protein 1, transcript variant X6
ADP-ribosylation factor GTPase activating protein 1, transcript variant X4
ADP-ribosylation factor GTPase activating protein 1, transcript variant X7
ADP-ribosylation factor GTPase activating protein 1, transcript variant X1
ADP-ribosylation factor GTPase activating protein 1, transcript variant X9
ADP-ribosylation factor GTPase activating protein 1, transcript variant X8
ADP-ribosylation factor GTPase activating protein 1, transcript variant X10
ADP-ribosylation factor GTPase activating protein 1, transcript variant X2
ADP-ribosylation factor GTPase activating protein 1, transcript variant X5
ADP-ribosylation factor GTPase-activating protein 1 isoform X7
ADP-ribosylation factor GTPase-activating protein 1 isoform X6
ADP-ribosylation factor GTPase-activating protein 1 isoform X8
ADP-ribosylation factor GTPase-activating protein 1 isoform X2
ADP-ribosylation factor GTPase-activating protein 1 isoform X4
ADP-ribosylation factor GTPase-activating protein 1 isoform X1
ADP-ribosylation factor GTPase-activating protein 1 isoform X3
ADP-ribosylation factor GTPase-activating protein 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae)
sterile alpha motif domain-containing protein 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X1
zinc finger protein 512B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X5
zinc finger protein 512B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 512B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122560130, transcript variant X2
uncharacterized LOC122560130, transcript variant X4
uncharacterized LOC122560130, transcript variant X1
uncharacterized LOC122560130, transcript variant X3
uridine-cytidine kinase 1-like 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uridine-cytidine kinase 1-like 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uridine-cytidine kinase 1-like 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uridine-cytidine kinase-like 1 isoform X2
uridine-cytidine kinase-like 1 isoform X1
uridine-cytidine kinase-like 1 isoform X3
flocculation protein FLO11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
flocculation protein FLO11-like isoform X1
flocculation protein FLO11-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
flocculation protein FLO11-like isoform X3
flocculation protein FLO11-like, transcript variant X2
flocculation protein FLO11-like isoform X2
flocculation protein FLO11-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
flocculation protein FLO11-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
glucose-induced degradation protein 8 homolog, transcript variant X2
glucose-induced degradation protein 8 homolog, transcript variant X1
glucose-induced degradation protein 8 homolog isoform X1
glucose-induced degradation protein 8 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
class E basic helix-loop-helix protein 23-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
uncharacterized LOC122560135, transcript variant X1
uncharacterized LOC122560135, transcript variant X2
uncharacterized LOC122560136, transcript variant X1
uncharacterized LOC122560136, transcript variant X4
uncharacterized LOC122560136, transcript variant X3
uncharacterized LOC122560136, transcript variant X2
YTH N(6)-methyladenosine RNA binding protein 1, transcript variant X6
YTH N(6)-methyladenosine RNA binding protein 1, transcript variant X11
YTH N(6)-methyladenosine RNA binding protein 1, transcript variant X2
YTH N(6)-methyladenosine RNA binding protein 1, transcript variant X3
YTH N(6)-methyladenosine RNA binding protein 1, transcript variant X5
YTH N(6)-methyladenosine RNA binding protein 1, transcript variant X4
YTH N(6)-methyladenosine RNA binding protein 1, transcript variant X10
YTH N(6)-methyladenosine RNA binding protein 1, transcript variant X9
YTH N(6)-methyladenosine RNA binding protein 1, transcript variant X8
YTH domain-containing family protein 1 isoform X3
YTH domain-containing family protein 1 isoform X2
YTH N(6)-methyladenosine RNA binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
YTH N(6)-methyladenosine RNA binding protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
YTH N(6)-methyladenosine RNA binding protein 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
YTH domain-containing family protein 1 isoform X1
YTH domain-containing family protein 1 isoform X5
YTH domain-containing family protein 1 isoform X4
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like, transcript variant X7
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like, transcript variant X5
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like, transcript variant X4
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like, transcript variant X3
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like, transcript variant X1
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like, transcript variant X2
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like isoform X5
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4-like isoform X4
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like isoform X1
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4-like isoform X3
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4-like isoform X2
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3-like isoform X6
phosphoprotein associated with glycosphingolipid-enriched microdomains 1-like, transcript variant X1
phosphoprotein associated with glycosphingolipid-enriched microdomains 1-like, transcript variant X2
phosphoprotein associated with glycosphingolipid-enriched microdomains 1-like isoform X1
phosphoprotein associated with glycosphingolipid-enriched microdomains 1-like isoform X2
hairy/enhancer-of-split related with YRPW motif protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 46-like, transcript variant X1
zinc finger and BTB domain-containing protein 46-like, transcript variant X3
zinc finger and BTB domain-containing protein 46-like, transcript variant X2
zinc finger and BTB domain-containing protein 46-like isoform X1
zinc finger and BTB domain-containing protein 46-like isoform X2
zinc finger protein 704-like, transcript variant X2
zinc finger protein 704-like, transcript variant X1
protein-tyrosine kinase 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein-tyrosine kinase 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein-tyrosine kinase 6-like isoform X1
protein-tyrosine kinase 6-like isoform X2
tyrosine-protein kinase SRK3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tyrosine-protein kinase SRK3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tyrosine-protein kinase SRK3-like isoform X2
tyrosine-protein kinase SRK3-like isoform X1
uncharacterized LOC122560149, transcript variant X1
uncharacterized LOC122560149, transcript variant X2
protein-L-isoaspartate O-methyltransferase domain-containing protein 2-like, transcript variant X1
protein-L-isoaspartate O-methyltransferase domain-containing protein 2-like, transcript variant X2
protein-L-isoaspartate O-methyltransferase domain-containing protein 2-like isoform X1
protein-L-isoaspartate O-methyltransferase domain-containing protein 2-like isoform X2
myelin transcription factor 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
myelin transcription factor 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
myelin transcription factor 1b, transcript variant X5
myelin transcription factor 1b, transcript variant X3
myelin transcription factor 1b, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
myelin transcription factor 1b, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
myelin transcription factor 1b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
myelin transcription factor 1b, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
myelin transcription factor 1b, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
myelin transcription factor 1b, transcript variant X6
myelin transcription factor 1 isoform X5
myelin transcription factor 1 isoform X3
myelin transcription factor 1 isoform X2
myelin transcription factor 1 isoform X1
myelin transcription factor 1 isoform X4
myelin transcription factor 1 isoform X6
neuropeptides B/W receptor 2b, transcript variant X5
neuropeptides B/W receptor 2b, transcript variant X6
neuropeptides B/W receptor 2b, transcript variant X3
neuropeptides B/W receptor 2b, transcript variant X4
neuropeptides B/W receptor 2b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neuropeptides B/W receptor 2b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
opiate receptor-like 1, transcript variant X5
opiate receptor-like 1, transcript variant X4
opiate receptor-like 1, transcript variant X3
opiate receptor-like 1, transcript variant X1
opiate receptor-like 1, transcript variant X2
opiate receptor-like 1, transcript variant X6
protein LKAAEAR1-like, transcript variant X1
protein LKAAEAR1-like, transcript variant X3
protein LKAAEAR1-like, transcript variant X2
regulator of G protein signaling 19, transcript variant X1
regulator of G protein signaling 19, transcript variant X2
transcription elongation factor A protein 1-like, transcript variant X2
transcription elongation factor A protein 1-like, transcript variant X6
transcription elongation factor A protein 1-like, transcript variant X3
transcription elongation factor A protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transcription elongation factor A protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
transcription elongation factor A protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transcription elongation factor A protein 1-like, transcript variant X7
transcription elongation factor A protein 1-like isoform X2
transcription elongation factor A protein 1-like isoform X3
transcription elongation factor A protein 1-like isoform X4
transcription elongation factor A protein 1-like isoform X1
transcription elongation factor A protein 2-like isoform X5
transcription elongation factor A protein 2-like isoform X6
uncharacterized LOC122560157, transcript variant X1
uncharacterized LOC122560157, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CCM2 like scaffold protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
CCM2 like scaffold protein, transcript variant X2
cerebral cavernous malformations 2 protein-like isoform X1
cerebral cavernous malformations 2 protein-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein kinase HCK-like, transcript variant X1
tyrosine-protein kinase HCK-like, transcript variant X3
tyrosine-protein kinase HCK-like, transcript variant X4
tyrosine-protein kinase HCK-like, transcript variant X2
tyrosine-protein kinase HCK-like isoform X1
tyrosine-protein kinase HCK-like isoform X2
transmembrane 9 superfamily protein member 4, transcript variant X2
transmembrane 9 superfamily member 4 isoform X2
transmembrane 9 superfamily protein member 4, transcript variant X1
transmembrane 9 superfamily member 4 isoform X1
pleiomorphic adenoma gene-like 2, transcript variant X6
pleiomorphic adenoma gene-like 2, transcript variant X2
pleiomorphic adenoma gene-like 2, transcript variant X3
pleiomorphic adenoma gene-like 2, transcript variant X5
pleiomorphic adenoma gene-like 2, transcript variant X1
pleiomorphic adenoma gene-like 2, transcript variant X4
kinesin family member 3B, transcript variant X2
kinesin family member 3B, transcript variant X1
polycomb group protein ASXL1-like, transcript variant X2
polycomb group protein ASXL1-like, transcript variant X1
polycomb group protein ASXL1-like, transcript variant X3
polycomb group protein ASXL1-like, transcript variant X8
polycomb group protein ASXL1-like isoform X1
polycomb group protein ASXL1-like isoform X2
polycomb group protein ASXL1-like isoform X5
polycomb group protein ASXL1-like, transcript variant X4
polycomb group protein ASXL1-like, transcript variant X5
polycomb group protein ASXL1-like, transcript variant X7
polycomb group protein ASXL1-like isoform X3
polycomb group protein ASXL1-like, transcript variant X6
polycomb group protein ASXL1-like isoform X4
nucleolar protein 4-like b, transcript variant X1
nucleolar protein 4-like b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nucleolar protein 4-like b, transcript variant X3
nucleolar protein 4-like b, transcript variant X2
nucleolar protein 4-like b, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nucleolar protein 4-like b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nucleolar protein 4-like b, transcript variant X8
nucleolar protein 4-like b, transcript variant X6
nucleolar protein 4-like b, transcript variant X9
DNA (cytosine-5-)-methyltransferase 3 beta, duplicate b.1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DNA (cytosine-5-)-methyltransferase 3 beta, duplicate b.1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DNA (cytosine-5-)-methyltransferase 3 beta, duplicate b.1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DNA (cytosine-5-)-methyltransferase 3 beta, duplicate b.1, transcript variant X9
DNA (cytosine-5-)-methyltransferase 3 beta, duplicate b.1, transcript variant X4
DNA (cytosine-5-)-methyltransferase 3 beta, duplicate b.1, transcript variant X6
DNA (cytosine-5-)-methyltransferase 3 beta, duplicate b.1, transcript variant X11
DNA (cytosine-5-)-methyltransferase 3 beta, duplicate b.1, transcript variant X2
DNA (cytosine-5-)-methyltransferase 3 beta, duplicate b.1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DNA (cytosine-5-)-methyltransferase 3 beta, duplicate b.1, transcript variant X5
DNA (cytosine-5-)-methyltransferase 3 beta, duplicate b.1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DNA (cytosine-5)-methyltransferase 3B isoform X1
DNA (cytosine-5)-methyltransferase 3B isoform X7
DNA (cytosine-5)-methyltransferase 3B isoform X5
DNA (cytosine-5)-methyltransferase 3B isoform X3
DNA (cytosine-5)-methyltransferase 3B isoform X2
DNA (cytosine-5)-methyltransferase 3B isoform X4
DNA (cytosine-5)-methyltransferase 3B isoform X8
DNA (cytosine-5)-methyltransferase 3B isoform X6
uncharacterized LOC122560175, transcript variant X1
uncharacterized LOC122560175, transcript variant X6
uncharacterized LOC122560175, transcript variant X2
uncharacterized LOC122560175, transcript variant X5
uncharacterized LOC122560175, transcript variant X3
uncharacterized LOC122560175, transcript variant X4
microtubule-associated protein RP/EB family member 1-like, transcript variant X1
microtubule-associated protein RP/EB family member 1-like, transcript variant X5
microtubule-associated protein RP/EB family member 1-like, transcript variant X4
microtubule-associated protein RP/EB family member 1-like, transcript variant X2
microtubule-associated protein RP/EB family member 1-like, transcript variant X3
microtubule-associated protein RP/EB family member 1-like isoform X1
microtubule-associated protein RP/EB family member 1-like isoform X2
acyl-CoA synthetase short chain family member 2, transcript variant X1
acyl-CoA synthetase short chain family member 2, transcript variant X2
acetyl-coenzyme A synthetase, cytoplasmic isoform X1
acetyl-coenzyme A synthetase, cytoplasmic isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
suppressor of glucose, autophagy associated 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
suppressor of glucose, autophagy associated 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
suppressor of glucose, autophagy associated 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
suppressor of glucose, autophagy associated 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase T-like, transcript variant X6
receptor-type tyrosine-protein phosphatase T-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase T-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase T-like, transcript variant X1
receptor-type tyrosine-protein phosphatase T-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase T-like, transcript variant X4
receptor-type tyrosine-protein phosphatase T-like isoform X5
receptor-type tyrosine-protein phosphatase T-like isoform X4
receptor-type tyrosine-protein phosphatase T-like isoform X3
receptor-type tyrosine-protein phosphatase T-like isoform X2
receptor-type tyrosine-protein phosphatase T-like isoform X6
receptor-type tyrosine-protein phosphatase T-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
vesicular inhibitory amino acid transporter
rho GTPase-activating protein 40-like, transcript variant X3
rho GTPase-activating protein 40-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
rho GTPase-activating protein 40-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rho GTPase-activating protein 40-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
rho GTPase-activating protein 40-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
rho GTPase-activating protein 40-like isoform X2
rho GTPase-activating protein 40-like isoform X1
rho GTPase-activating protein 40-like isoform X4
rho GTPase-activating protein 18-like isoform X3
L3MBTL histone methyl-lysine binding protein 1, transcript variant X4
L3MBTL histone methyl-lysine binding protein 1, transcript variant X1
L3MBTL histone methyl-lysine binding protein 1, transcript variant X3
L3MBTL histone methyl-lysine binding protein 1, transcript variant X2
lethal(3)malignant brain tumor-like protein 1 isoform X2
lethal(3)malignant brain tumor-like protein 1 isoform X1
serine/arginine-rich splicing factor 6-like
band 4.1-like protein 3, transcript variant X8
band 4.1-like protein 3, transcript variant X1
band 4.1-like protein 3, transcript variant X6
band 4.1-like protein 3, transcript variant X5
band 4.1-like protein 3, transcript variant X7
band 4.1-like protein 3, transcript variant X4
band 4.1-like protein 3, transcript variant X2
band 4.1-like protein 3, transcript variant X3
AAR2 splicing factor, transcript variant X1
AAR2 splicing factor, transcript variant X3
AAR2 splicing factor, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
disks large-associated protein 4-like, transcript variant X1
disks large-associated protein 4-like, transcript variant X2
disks large-associated protein 4-like isoform X1
disks large-associated protein 4-like isoform X2
homeobox protein TGIF2-like, transcript variant X3
homeobox protein TGIF2-like, transcript variant X4
homeobox protein TGIF2-like, transcript variant X2
homeobox protein TGIF2-like, transcript variant X1
homeobox protein TGIF2-like, transcript variant X6
homeobox protein TGIF2-like, transcript variant X5
myosin regulatory light polypeptide 9, transcript variant X2
myosin regulatory light polypeptide 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X1
growth hormone releasing hormone, transcript variant X2
growth hormone releasing hormone, transcript variant X1
mannosidase beta like, transcript variant X3
mannosidase beta like, transcript variant X4
mannosidase beta like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mannosidase beta like, transcript variant X6
mannosidase beta like, transcript variant X5
mannosidase beta like, transcript variant X2
proto-oncogene tyrosine-protein kinase Src-like, transcript variant X1
proto-oncogene tyrosine-protein kinase Src-like, transcript variant X2
proto-oncogene tyrosine-protein kinase Src-like isoform X1
proto-oncogene tyrosine-protein kinase Src-like isoform X2
neurotensin receptor 1 (high affinity), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neurotensin receptor 1 (high affinity), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier organic anion transporter family, member 4A1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier organic anion transporter family, member 4A1, transcript variant X2
solute carrier organic anion transporter family, member 4A1, transcript variant X3
solute carrier organic anion transporter family member 4A1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC122560208, transcript variant X3
uncharacterized LOC122560208, transcript variant X1
uncharacterized LOC122560208, transcript variant X4
uncharacterized LOC122560208, transcript variant X2
uncharacterized LOC122560208, transcript variant X6
uncharacterized LOC122560208, transcript variant X7
uncharacterized LOC122560208, transcript variant X5
uncharacterized LOC122560207, transcript variant X2
uncharacterized protein LOC122560207 isoform X2
uncharacterized LOC122560207, transcript variant X1
uncharacterized protein LOC122560207 isoform X1
uncharacterized LOC122560207, transcript variant X4
uncharacterized LOC122560207, transcript variant X5
uncharacterized LOC122560207, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC122559918, transcript variant X2
uncharacterized LOC122559918, transcript variant X1
uncharacterized LOC122559918, transcript variant X3
GATA binding protein 5, transcript variant X3
GATA binding protein 5, transcript variant X1
GATA binding protein 5, transcript variant X2
retinoblastoma binding protein 8-like, transcript variant X4
retinoblastoma binding protein 8-like, transcript variant X1
retinoblastoma binding protein 8-like, transcript variant X5
retinoblastoma binding protein 8-like, transcript variant X6
retinoblastoma binding protein 8-like, transcript variant X3
retinoblastoma binding protein 8-like, transcript variant X2
uncharacterized protein rbbp8l isoform X2
uncharacterized protein rbbp8l isoform X3
uncharacterized protein rbbp8l isoform X1
uncharacterized protein rbbp8l isoform X4
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Cdk5 and Abl enzyme substrate 2b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
CDK5 and ABL1 enzyme substrate 2 isoform X1
Cdk5 and Abl enzyme substrate 2b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
CDK5 and ABL1 enzyme substrate 2 isoform X2
ribosomal protein S21, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
ribosomal protein S21, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
oxysterol binding protein-like 2b, transcript variant X2
oxysterol binding protein-like 2b, transcript variant X1
oxysterol-binding protein-related protein 2b
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: histamine H3 receptor-like
uncharacterized protein SCO4629-like, transcript variant X1
uncharacterized protein SCO4629-like, transcript variant X2
uncharacterized protein SCO4629-like, transcript variant X3
mitochondrial ribosome-associated GTPase 2, transcript variant X4
mitochondrial ribosome-associated GTPase 2, transcript variant X3
mitochondrial ribosome-associated GTPase 2, transcript variant X1
mitochondrial ribosome-associated GTPase 2, transcript variant X2
mitochondrial ribosome-associated GTPase 2 isoform X2
mitochondrial ribosome-associated GTPase 2 isoform X1
calcium-responsive transactivator-like, transcript variant X2
calcium-responsive transactivator-like, transcript variant X4
calcium-responsive transactivator-like, transcript variant X1
calcium-responsive transactivator-like isoform X2
calcium-responsive transactivator-like isoform X1
calcium-responsive transactivator-like isoform X4
calcium-responsive transactivator-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
calcium-responsive transactivator-like isoform X3
LSM family member 14B, transcript variant X6
LSM family member 14B, transcript variant X5
LSM family member 14B, transcript variant X4
LSM family member 14B, transcript variant X3
LSM family member 14B, transcript variant X2
LSM family member 14B, transcript variant X1
TAF4A RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
TAF4A RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transcription initiation factor TFIID subunit 4 isoform X1
transcription initiation factor TFIID subunit 4 isoform X2
v-myb avian myeloblastosis viral oncogene homolog-like 2b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
v-myb avian myeloblastosis viral oncogene homolog-like 2b, transcript variant X1
v-myb avian myeloblastosis viral oncogene homolog-like 2b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
v-myb avian myeloblastosis viral oncogene homolog-like 2b isoform X2
v-myb avian myeloblastosis viral oncogene homolog-like 2b isoform X1
intraflagellar transport 52 homolog (Chlamydomonas), transcript variant X1
intraflagellar transport 52 homolog (Chlamydomonas), transcript variant X2
intraflagellar transport protein 52 homolog isoform X1
intraflagellar transport protein 52 homolog isoform X2
serum/glucocorticoid regulated kinase 2a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serum/glucocorticoid regulated kinase 2a, transcript variant X8
serum/glucocorticoid regulated kinase 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serum/glucocorticoid regulated kinase 2a, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serum/glucocorticoid regulated kinase 2a, transcript variant X2
serum/glucocorticoid regulated kinase 2a, transcript variant X10
serum/glucocorticoid regulated kinase 2a, transcript variant X4
serum/glucocorticoid regulated kinase 2a, transcript variant X6
serum/glucocorticoid regulated kinase 2a, transcript variant X5
serum/glucocorticoid regulated kinase 2a, transcript variant X7
solute carrier family 2 member 10, transcript variant X1
solute carrier family 2 member 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 2 member 10, transcript variant X2
solute carrier family 2, facilitated glucose transporter member 10 isoform X2
solute carrier family 2, facilitated glucose transporter member 10 isoform X1
eyes absent homolog 1-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
eyes absent homolog 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
eyes absent homolog 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
eyes absent homolog 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
eyes absent homolog 1-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
eyes absent homolog 1-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
eyes absent homolog 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
eyes absent homolog 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
eyes absent homolog 1-like, transcript variant X2
eyes absent homolog 1-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
eyes absent homolog 1-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger, MYND-type containing 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger, MYND-type containing 8, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger, MYND-type containing 8, transcript variant X10
zinc finger, MYND-type containing 8, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger, MYND-type containing 8, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger, MYND-type containing 8, transcript variant X5
zinc finger, MYND-type containing 8, transcript variant X9
zinc finger, MYND-type containing 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger, MYND-type containing 8, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger, MYND-type containing 8, transcript variant X1
protein kinase C-binding protein 1 isoform X3
protein kinase C-binding protein 1 isoform X9
protein kinase C-binding protein 1 isoform X10
protein kinase C-binding protein 1 isoform X6
protein kinase C-binding protein 1 isoform X5
protein kinase C-binding protein 1 isoform X8
protein kinase C-binding protein 1 isoform X2
protein kinase C-binding protein 1 isoform X7
protein kinase C-binding protein 1 isoform X1
zinc finger, MYND-type containing 8, transcript variant X4
protein kinase C-binding protein 1 isoform X4
translocating chain-associated membrane protein 1-like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
translocating chain-associated membrane protein 1-like 1, transcript variant X4
translocating chain-associated membrane protein 1-like 1, transcript variant X1
translocating chain-associated membrane protein 1-like 1, transcript variant X2
translocating chain-associated membrane protein 1-like 1 isoform X1
translocating chain-associated membrane protein 1-like 1 isoform X2
nuclear receptor coactivator 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
nuclear receptor coactivator 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nuclear receptor coactivator 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nuclear receptor coactivator 3-like isoform X1
nuclear receptor coactivator 3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
transcription factor MafB-like, transcript variant X1
transcription factor MafB-like, transcript variant X2
DNA topoisomerase 1, transcript variant X1
DNA topoisomerase 1, transcript variant X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1
zinc fingers and homeoboxes protein 3-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc fingers and homeoboxes protein 3-like, transcript variant X8
zinc fingers and homeoboxes protein 3-like, transcript variant X7
zinc fingers and homeoboxes protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc fingers and homeoboxes protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc fingers and homeoboxes protein 3-like, transcript variant X3
zinc fingers and homeoboxes protein 3-like, transcript variant X5
zinc fingers and homeoboxes protein 3-like, transcript variant X9
zinc fingers and homeoboxes protein 3-like, transcript variant X6
zinc fingers and homeoboxes protein 3-like, transcript variant X4
zinc fingers and homeoboxes protein 3-like isoform X2
zinc fingers and homeoboxes protein 3-like isoform X1
probable ATP-dependent RNA helicase DHX35
protein phosphatase 1 regulatory inhibitor subunit 16B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein phosphatase 1 regulatory inhibitor subunit 16B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein phosphatase 1 regulatory inhibitor subunit 16B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein phosphatase 1 regulatory inhibitor subunit 16B-like isoform X1
protein phosphatase 1 regulatory inhibitor subunit 16B-like isoform X2
solute carrier family 13 member 3-like, transcript variant X1
solute carrier family 13 member 3-like, transcript variant X3
solute carrier family 13 member 3-like, transcript variant X2
solute carrier family 13 member 3-like, transcript variant X4
solute carrier family 13 member 3-like isoform X1
solute carrier family 13 member 3-like isoform X2
solute carrier family 13 member 3-like isoform X3
solute carrier family 13 member 3-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
osteoclast stimulatory transmembrane protein-like
cylindromatosis (turban tumor syndrome), b, transcript variant X1
cylindromatosis (turban tumor syndrome), b, transcript variant X2
ubiquitin carboxyl-terminal hydrolase CYLD isoform X2
ubiquitin carboxyl-terminal hydrolase CYLD isoform X1
cylindromatosis (turban tumor syndrome), b, transcript variant X3
ubiquitin carboxyl-terminal hydrolase CYLD isoform X3
nuclear receptor coactivator 6, transcript variant X4
nuclear receptor coactivator 6, transcript variant X1
nuclear receptor coactivator 6, transcript variant X2
nuclear receptor coactivator 6, transcript variant X5
nuclear receptor coactivator 6, transcript variant X3
nuclear receptor coactivator 6 isoform X1
nuclear receptor coactivator 6 isoform X4
nuclear receptor coactivator 6 isoform X2
nuclear receptor coactivator 6 isoform X3
tumor protein p53-inducible nuclear protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
tumor protein p53-inducible nuclear protein 2, transcript variant X2
tumor protein p53-inducible nuclear protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
tumor protein p53-inducible nuclear protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
tumor protein p53-inducible nuclear protein 2, transcript variant X5
tumor protein p53-inducible nuclear protein 2, transcript variant X4
tumor protein p53-inducible nuclear protein 2 isoform X2
tumor protein p53-inducible nuclear protein 2 isoform X1
phosphatidylinositol glycan anchor biosynthesis, class U
phosphatidylinositol glycan anchor biosynthesis class U protein
microtubule-associated proteins 1A/1B light chain 3A, transcript variant X2
microtubule-associated proteins 1A/1B light chain 3A, transcript variant X1
microtubule-associated proteins 1A/1B light chain 3A isoform X2
microtubule-associated proteins 1A/1B light chain 3A isoform X1
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ER degradation enhancer, mannosidase alpha-like 2, transcript variant X2
ER degradation enhancer, mannosidase alpha-like 2, transcript variant X1
ER degradation-enhancing alpha-mannosidase-like protein 2 isoform X2
ER degradation-enhancing alpha-mannosidase-like protein 2 isoform X1
protein NDRG3-like, transcript variant X5
protein NDRG3-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein NDRG3-like, transcript variant X9
protein NDRG3-like, transcript variant X1
protein NDRG3-like, transcript variant X3
protein NDRG3-like, transcript variant X2
protein NDRG3-like, transcript variant X8
protein NDRG3-like, transcript variant X7
protein NDRG3-like, transcript variant X4
src-like-adapter 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
src-like-adapter 2, transcript variant X2
PHD finger protein 20, b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
PHD finger protein 20, b, transcript variant X4
PHD finger protein 20, b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
PHD finger protein 20, b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
PHD finger protein 20, b, transcript variant X1
Rho GTPase activating protein 46b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Rho GTPase activating protein 46b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Rho GTPase activating protein 46b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Rho GTPase activating protein 46b, transcript variant X1
Rho GTPase activating protein 46b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Rho GTPase activating protein 46b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rho GTPase-activating protein 39 isoform X2
rho GTPase-activating protein 39 isoform X1
rho GTPase-activating protein 39 isoform X3
rho GTPase-activating protein 39 isoform X4
histocompatibility (minor) 13, transcript variant X2
histocompatibility (minor) 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
minor histocompatibility antigen H13 isoform X2
minor histocompatibility antigen H13 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
N-terminal EF-hand calcium-binding protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein CBFA2T1-like, transcript variant X9
protein CBFA2T1-like, transcript variant X1
protein CBFA2T1-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein CBFA2T1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein CBFA2T1-like, transcript variant X5
protein CBFA2T1-like, transcript variant X2
protein CBFA2T1-like, transcript variant X4
protein CBFA2T1-like, transcript variant X6
protein CBFA2T1-like, transcript variant X7
dynein light chain roadblock-type 2-like
SAM domain and HD domain 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
SAM domain and HD domain 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
deoxynucleoside triphosphate triphosphohydrolase SAMHD1 isoform X1
deoxynucleoside triphosphate triphosphohydrolase SAMHD1 isoform X2
deoxynucleoside triphosphate triphosphohydrolase SAMHD1-like, transcript variant X3
deoxynucleoside triphosphate triphosphohydrolase SAMHD1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
deoxynucleoside triphosphate triphosphohydrolase SAMHD1-like, transcript variant X1
deoxynucleoside triphosphate triphosphohydrolase SAMHD1-like isoform X3
deoxynucleoside triphosphate triphosphohydrolase SAMHD1-like isoform X2
deoxynucleoside triphosphate triphosphohydrolase SAMHD1-like isoform X1
solute carrier family 52 member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 52 member 3, transcript variant X2
solute carrier family 52, riboflavin transporter, member 3-A isoform X1
solute carrier family 52, riboflavin transporter, member 3-A isoform X2
transcriptional repressor scratch 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sulfiredoxin 1 homolog (S. cerevisiae), transcript variant X2
sulfiredoxin 1 homolog (S. cerevisiae), transcript variant X1
uncharacterized protein srxn1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
casein kinase II subunit alpha, transcript variant X10
casein kinase II subunit alpha, transcript variant X9
casein kinase II subunit alpha, transcript variant X7
casein kinase II subunit alpha, transcript variant X4
casein kinase II subunit alpha, transcript variant X3
casein kinase II subunit alpha, transcript variant X1
casein kinase II subunit alpha, transcript variant X5
casein kinase II subunit alpha, transcript variant X2
casein kinase II subunit alpha, transcript variant X6
casein kinase II subunit alpha, transcript variant X11
casein kinase II subunit alpha isoform X1
casein kinase II subunit alpha isoform X4
casein kinase II subunit alpha isoform X2
casein kinase II subunit alpha isoform X5
casein kinase II subunit alpha, transcript variant X8
casein kinase II subunit alpha isoform X3
casein kinase II subunit alpha isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
TBC1 domain family, member 20, transcript variant X1
TBC1 domain family, member 20, transcript variant X2
RanBP-type and C3HC4-type zinc finger containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
ranBP-type and C3HC4-type zinc finger-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 1, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
chromosome 20 C20orf96 homolog, transcript variant X2
chromosome 20 C20orf96 homolog, transcript variant X1
uncharacterized protein C20orf96 homolog isoform X1
uncharacterized protein C20orf96 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein kinase 3/4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
potassium voltage-gated channel subfamily S member 2, transcript variant X7
potassium voltage-gated channel subfamily S member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel subfamily S member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily S member 2, transcript variant X3
potassium voltage-gated channel subfamily S member 2, transcript variant X2
potassium voltage-gated channel subfamily S member 2, transcript variant X5
potassium voltage-gated channel subfamily S member 2, transcript variant X6
potassium voltage-gated channel subfamily S member 2 isoform X2
potassium voltage-gated channel subfamily S member 2 isoform X1
recombination signal binding protein for immunoglobulin kappa J region-like
recombining binding protein suppressor of hairless-like protein
oxidative stress responsive serine-rich 1, transcript variant X1
oxidative stress responsive serine-rich 1, transcript variant X2
oxidative stress responsive serine-rich 1, transcript variant X3
oxidative stress-responsive serine-rich protein 1
growth differentiation factor 5, transcript variant X3
growth differentiation factor 5, transcript variant X2
growth differentiation factor 5, transcript variant X4
growth differentiation factor 5, transcript variant X1
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X1
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X2
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X3
family with sequence similarity 83 member C
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
charged multivesicular body protein 4Ba, transcript variant X1
charged multivesicular body protein 4Ba, transcript variant X2
charged multivesicular body protein 4b isoform X1
charged multivesicular body protein 4b isoform X2
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X4
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X3
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X1
RALY heterogeneous nuclear ribonucleoprotein, transcript variant X2
eukaryotic translation initiation factor 2, subunit 2 beta, transcript variant X1
eukaryotic translation initiation factor 2, subunit 2 beta, transcript variant X2
eukaryotic translation initiation factor 2 subunit 2 isoform X1
eukaryotic translation initiation factor 2 subunit 2 isoform X2
peptidyl-prolyl cis-trans isomerase FKBP1A-like
double-strand-break repair protein rad21 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
complex I assembly factor TIMMDC1, mitochondrial-like
death-inducer obliterator 1-like, transcript variant X1
death-inducer obliterator 1-like, transcript variant X2
transcription factor-like 5 protein, transcript variant X1
transcription factor-like 5 protein, transcript variant X2
transcription factor-like 5 protein, transcript variant X3
transcription factor-like 5 protein, transcript variant X4
transcription factor-like 5 protein isoform X1
transcription factor-like 5 protein isoform X2
transcription factor-like 5 protein isoform X3
transcription factor-like 5 protein isoform X4
opioid growth factor receptor-like protein 1, transcript variant X1
opioid growth factor receptor-like protein 1, transcript variant X5
opioid growth factor receptor-like protein 1, transcript variant X3
opioid growth factor receptor-like protein 1, transcript variant X2
opioid growth factor receptor-like protein 1, transcript variant X4
opioid growth factor receptor-like protein 1 isoform X5
opioid growth factor receptor-like protein 1 isoform X3
opioid growth factor receptor-like protein 1 isoform X1
opioid growth factor receptor-like protein 1 isoform X2
opioid growth factor receptor-like protein 1 isoform X4
translocase of outer mitochondrial membrane 34
mitochondrial import receptor subunit TOM34
embryonic polyadenylate-binding protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
embryonic polyadenylate-binding protein-like, transcript variant X2
embryonic polyadenylate-binding protein-like, transcript variant X1
embryonic polyadenylate-binding protein-like isoform X1
embryonic polyadenylate-binding protein-like isoform X2
14-3-3 protein beta/alpha-1-like, transcript variant X2
14-3-3 protein beta/alpha-1-like, transcript variant X1
14-3-3 protein beta/alpha-1-like, transcript variant X3
14-3-3 protein beta/alpha-1-like isoform X1
14-3-3 protein beta/alpha-1-like isoform X2
neurocalcin-delta-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neurocalcin-delta-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neurocalcin-delta-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
neurocalcin-delta-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
regulating synaptic membrane exocytosis protein 4-like
potassium channel subfamily K member 9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neuronal acetylcholine receptor subunit alpha-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 2-like, transcript variant X3
potassium voltage-gated channel subfamily KQT member 2-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 2-like, transcript variant X4
potassium voltage-gated channel subfamily KQT member 2-like, transcript variant X1
potassium voltage-gated channel subfamily KQT member 2-like isoform X5
potassium voltage-gated channel subfamily KQT member 2-like isoform X3
potassium voltage-gated channel subfamily KQT member 2-like isoform X7
potassium voltage-gated channel subfamily KQT member 2-like isoform X2
potassium voltage-gated channel subfamily KQT member 2-like isoform X4
potassium voltage-gated channel subfamily KQT member 2-like isoform X1
potassium voltage-gated channel subfamily KQT member 2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 2-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 2-like, transcript variant X6
potassium voltage-gated channel subfamily KQT member 2-like isoform X6
tyrosine-protein kinase HCK-like isoform X3
RNA binding motif protein 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
RNA binding motif protein 12, transcript variant X3
RNA binding motif protein 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
TOX high mobility group box family member 2, transcript variant X2
TOX high mobility group box family member 2, transcript variant X1
TOX high mobility group box family member 2 isoform X2
TOX high mobility group box family member 2 isoform X1
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X11
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X10
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X8
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X6
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X7
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X3
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X5
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X4
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X1
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X9
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X18
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X17
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X13
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X14
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X12
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X16
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X15
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X19
Ral GTPase activating protein non-catalytic subunit beta, transcript variant X2
ral GTPase-activating protein subunit beta isoform X15
ral GTPase-activating protein subunit beta isoform X14
ral GTPase-activating protein subunit beta isoform X18
ral GTPase-activating protein subunit beta isoform X8
ral GTPase-activating protein subunit beta isoform X10
ral GTPase-activating protein subunit beta isoform X9
ral GTPase-activating protein subunit beta isoform X17
ral GTPase-activating protein subunit beta isoform X7
ral GTPase-activating protein subunit beta isoform X5
ral GTPase-activating protein subunit beta isoform X6
ral GTPase-activating protein subunit beta isoform X16
ral GTPase-activating protein subunit beta isoform X12
ral GTPase-activating protein subunit beta isoform X2
ral GTPase-activating protein subunit beta isoform X4
ral GTPase-activating protein subunit beta isoform X13
ral GTPase-activating protein subunit beta isoform X3
ral GTPase-activating protein subunit beta isoform X11
ral GTPase-activating protein subunit beta isoform X1
chromodomain helicase DNA binding protein 6, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
chromodomain helicase DNA binding protein 6, transcript variant X4
chromodomain helicase DNA binding protein 6, transcript variant X5
chromodomain-helicase-DNA-binding protein 6 isoform X4
chromodomain helicase DNA binding protein 6, transcript variant X3
chromodomain-helicase-DNA-binding protein 6 isoform X3
chromodomain helicase DNA binding protein 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
chromodomain helicase DNA binding protein 6, transcript variant X2
chromodomain helicase DNA binding protein 6, transcript variant X7
chromodomain-helicase-DNA-binding protein 6 isoform X1
chromodomain-helicase-DNA-binding protein 6 isoform X2
chromodomain-helicase-DNA-binding protein 6 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
retinoblastoma-like protein 1, transcript variant X2
retinoblastoma-like protein 1, transcript variant X1
endoplasmic reticulum-Golgi intermediate compartment protein 3
cytochrome c1, heme protein, mitochondrial
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like, transcript variant X3
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like, transcript variant X2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like, transcript variant X4
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like, transcript variant X1
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like isoform X2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like isoform X1
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like isoform X3
oxidative stress induced growth inhibitor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
eukaryotic translation initiation factor 6
matrix metallopeptidase 24, transcript variant X2
matrix metallopeptidase 24, transcript variant X1
short transient receptor potential channel 4-associated protein-like, transcript variant X2
short transient receptor potential channel 4-associated protein-like, transcript variant X1
short transient receptor potential channel 4-associated protein-like isoform X2
short transient receptor potential channel 4-associated protein-like isoform X1
tubulin delta chain-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tubulin delta chain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tubulin delta chain-like, transcript variant X1
tubulin delta chain-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
gastrula zinc finger protein XlCGF7.1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3
StAR-related lipid transfer (START) domain containing 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns